Literature DB >> 8662115

Optimal collimator choice for sequential iodine-123 and technetium-99m imaging.

F D Geeter1, P R Franken, M Defrise, H Andries, E Saelens, A Bossuyt.   

Abstract

Dual-isotope studies with technetium-99m and iodine-123 may be useful for various organs, including brain and myocardium. For the images obtained with each of the tracers to be comparable, it is important that activity ratios (activity in one part of the image/reference activity in the image) are preserved by the imaging method. We have used a Rollo phantom to study how collimator response affects such ratios. All investigations were performed with 123I(p,5n) and on a Siemens Orbiter 3700 camera fitted with either a low-energy high-resolution (LEHR) or a medium-energy (ME) collimator. Images were made of a Rollo phantom filled with an aqueous solution of either 99Tc or 123I, and placed on the collimator surface with 8 cm of methyl-methacrylate interposed. Count densities were measured in ROIs drawn in each cell of the phantom, and normalised to the maximal ROI value in the image. The mean square error (MSE) was used to assess how well the ratios of count densities approximated the known activity ratios based on the dimensions of the cells of the phantom. For 99mTc, regardless of the collimator used, the count density ratios approximated the activity ratios fairly well (LEHR: MSE=0.008; ME: MSE=0.020). For 123I, count density ratios obtained with the LEHR were consistently higher than activity ratios (MSE=0. 235), whereas the differences between the measured and the theoretical values were less with the ME collimator (MSE=0.013). Contrast fidelity of the 123I images obtained with the LEHR collimator could be improved with Jaszczak scatter correction with k=1, but this led to unfavourable signal-to-noise ratios. For sequential 99mTc/123I studies with extended sources, ME is to be preferred because of its higher contrast accuracy. Spatial resolution is less for the ME than for the LEHR collimator (FWHM with scatter: LEHR/99mTc=6.9 mm, LEHR/123I=7.4 mm, ME/99mTc= 10.1 mm, ME/123I=11.1 mm), but remains similar for both tracers when the ME is used.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662115     DOI: 10.1007/bf00843705

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: validation by phantom studies.

Authors:  M D Devous; J L Lowe; J K Payne
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

2.  Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT.

Authors:  M D Devous; J K Payne; J L Lowe
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

3.  SPECT dual-energy-window Compton correction: scatter multiplier required for quantification.

Authors:  K F Koral; F M Swailem; S Buchbinder; N H Clinthorne; W L Rogers; B M Tsui
Journal:  J Nucl Med       Date:  1990-01       Impact factor: 10.057

4.  Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodies.

Authors:  D J Macey; G L DeNardo; S J DeNardo; H H Hines
Journal:  J Nucl Med       Date:  1986-09       Impact factor: 10.057

5.  Feasibility of dual radionuclide brain imaging with I-123 and Tc-99m.

Authors:  M Ivanovic; D A Weber; S Loncaric; D Franceschi
Journal:  Med Phys       Date:  1994-05       Impact factor: 4.071

6.  Volume and activity quantitation with iodine-123 SPECT.

Authors:  D R Gilland; R J Jaszczak; T G Turkington; K L Greer; R E Coleman
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

7.  Improved SPECT quantification using compensation for scattered photons.

Authors:  R J Jaszczak; K L Greer; C E Floyd; C C Harris; R E Coleman
Journal:  J Nucl Med       Date:  1984-08       Impact factor: 10.057

8.  Performance of collimators used for tomographic imaging of I-123 contaminated with I-124.

Authors:  J F Polak; R J English; B L Holman
Journal:  J Nucl Med       Date:  1983-11       Impact factor: 10.057

9.  Quantitative SPECT reconstruction of iodine-123 data.

Authors:  D R Gilland; R J Jaszczak; K L Greer; R E Coleman
Journal:  J Nucl Med       Date:  1991-03       Impact factor: 10.057

10.  Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve.

Authors:  P R Franken; F De Geeter; P Dendale; D Demoor; P Block; A Bossuyt
Journal:  J Nucl Med       Date:  1994-11       Impact factor: 10.057

  10 in total
  9 in total

1.  Collimator choice in cardiac SPECT with I-123-labeled tracers.

Authors:  Yusuke Inoue; Ichiro Shirouzu; Toru Machida; Yasunori Yoshizawa; Fumihide Akita; Manabu Minami; Kuni Ohtomo
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

2.  Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging.

Authors:  Ji Chen; Ernest V Garcia; James R Galt; Russell D Folks; Ignasi Carrio
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

3.  Septal penetration in iodine-123 metaiodobenzylguanidine cardiac sympathetic imaging using a medium-energy collimator.

Authors:  Yusuke Inoue; Yutaka Abe; Yuji Asano; Kei Kikuchi; Takahiro Iizuka; Kazutoshi Nishiyama
Journal:  J Nucl Cardiol       Date:  2013-10-23       Impact factor: 5.952

4.  An improved method for estimating the heart-to-mediastinum ratio from cardiac sympathetic nerve imaging with low-energy high-resolution collimators.

Authors:  Yusuke Inoue; Yutaka Abe; Yuji Asano; Kei Kikuchi; Keiji Matsunaga; Takahiro Iizuka; Kazutoshi Nishiyama
Journal:  J Nucl Cardiol       Date:  2014-04-09       Impact factor: 5.952

5.  Assessment of perfusion, function, and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging.

Authors:  H Everaert; C Vanhove; P R Franken
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

6.  123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients.

Authors:  Marleen Keyaerts; Tony Lahoutte; Bart Neyns; Vicky Caveliers; Chris Vanhove; Hendrik Everaert; Ken Kersemans; Philippe R Franken; John Mertens; Axel Bossuyt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-20       Impact factor: 9.236

7.  Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake.

Authors:  Yusuke Inoue; Akira Suzuki; Ichiro Shirouzu; Toru Machida; Yasunori Yoshizawa; Fumihide Akita; Satoshi Ohnishi; Kohki Yoshikawa; Kuni Ohtomo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

8.  An energy-optimized collimator design for a CZT-based SPECT camera.

Authors:  Fenghua Weng; Srijeeta Bagchi; Yunlong Zan; Qiu Huang; Youngho Seo
Journal:  Nucl Instrum Methods Phys Res A       Date:  2016-01-11       Impact factor: 1.455

9.  A European myocardial 123I-mIBG cross-calibration phantom study.

Authors:  Derk O Verschure; Edwin Poel; Kenichi Nakajima; Koichi Okuda; Berthe L F van Eck-Smit; G Aernout Somsen; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2017-01-24       Impact factor: 5.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.